Giftify (GIFT) announced a significant increase in gift card sales following its announcement of a smart savings program for GLP-1 diabetes and weight loss medications. CardCash.com, Giftify’s secondary gift card exchange platform, experienced an overall 916% week-over-week, w/w, increase in the face value of gift cards sold across major pharmacy retailers. This surge follows the Company’s recent announcement of innovative savings opportunities for consumers purchasing high-cost prescription medications such as Ozempic from Novo Nordisk (NVO) and Zepbound from Eli Lilly (LLY), in addition to increased consumer demand for seasonal cold and flu remedies and other winter health products.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GIFT:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue